If you need more lookups,
subscriptions start at $34 USD/month.
Frank Marcoux Location
Alton, NH, US
Frank Marcoux Work
Board Member and Director @ Opsidio Pharmaceuticals, Leukogene Therapeutics (October 2013 - Present)
President @ Discovery Translation, LLC (April 2008 - January 2025)
CEO @ Leukogene Therapeutics, Inc. (July 2012 - November 2024)
CEO and Director @ Portage Glasgow Ltd (January 2018 - January 2021)
CEO and CSO @ Portage Pharmaceuticals Ltd (January 2017 - November 2019)
Advisor @ Indivumed, GmbH (March 2015 - March 2018)
Vice President Clinical Quantitative and Innovative Medicine and Vice President Biology Discipline @ (January 2006 - January 2008)
VP Discovery Biology @ PGRD (January 2002 - January 2004)
Vice President Biology @ Parke-Davis (January 1982 - January 1990)
Frank Marcoux Education
University of Alabama at Birmingham
PhD (Physiology and Biophysics)
1977-1979
Frank Marcoux Skills
Lifesciences
Clinical Research
Biotechnology
Pharmaceutical Industry
Oncology
Drug Development
Clinical Trials
Clinical Development
CRO
Toxicology
Diabetes
Regulatory Submissions
Pharmacology
Neuroscience
Drug Discovery
Frank Marcoux Summary
Frank Marcoux, based in Alton, NH, US, is currently a Board Member and Director at Opsidio Pharmaceuticals, Leukogene Therapeutics. Frank Marcoux brings experience from previous roles at Discovery Translation, LLC, Leukogene Therapeutics, Inc., Portage Glasgow Ltd and Portage Pharmaceuticals Ltd. Frank Marcoux holds a 1977 - 1979 PhD in Physiology and Biophysics @ University of Alabama at Birmingham. With a robust skill set that includes Lifesciences, Clinical Research, Biotechnology, Pharmaceutical Industry, Oncology and more. Frank Marcoux has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Frank Marcoux?
Find contact details for 700 million professionals.